Q3 EPS Forecast for Phibro Animal Health Lowered by Analyst

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research reduced their Q3 2025 earnings estimates for Phibro Animal Health in a research report issued on Wednesday, November 20th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.35 per share for the quarter, down from their prior estimate of $0.37. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q1 2026 earnings at $0.32 EPS, Q3 2026 earnings at $0.33 EPS and Q1 2027 earnings at $0.48 EPS.

Other research analysts have also issued research reports about the stock. Barclays boosted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Bank of America increased their target price on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, November 20th. Finally, JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company. Three analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $16.50.

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $23.74 on Monday. The company has a 50 day moving average price of $23.16 and a two-hundred day moving average price of $20.01. Phibro Animal Health has a 12-month low of $9.49 and a 12-month high of $25.98. The stock has a market capitalization of $961.47 million, a PE ratio of 55.21, a price-to-earnings-growth ratio of 0.61 and a beta of 0.51. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The company had revenue of $273.16 million during the quarter, compared to the consensus estimate of $262.44 million. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%.

Institutional Trading of Phibro Animal Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. CWM LLC lifted its stake in Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares during the period. nVerses Capital LLC acquired a new position in shares of Phibro Animal Health in the 3rd quarter worth approximately $70,000. Quantbot Technologies LP bought a new position in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. Summit Securities Group LLC acquired a new stake in Phibro Animal Health in the 2nd quarter valued at $83,000. Finally, China Universal Asset Management Co. Ltd. grew its position in Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after acquiring an additional 1,522 shares during the period. Institutional investors own 99.34% of the company’s stock.

Insider Buying and Selling at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction on Wednesday, September 4th. The shares were purchased at an average price of $20.02 per share, with a total value of $100,100.00. Following the acquisition, the director now directly owns 25,000 shares of the company’s stock, valued at $500,500. This represents a 25.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 50.07% of the company’s stock.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be paid a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.02%. Phibro Animal Health’s dividend payout ratio is 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.